Glycophthalocyanines as photosensitizers for triggering mitotic catastrophe and apoptosis in cancer cells

Chemical Research in Toxicology

Volumn 25, Issue 4, 2012, Pages 940-951

  Soares, Ana R M ^a,b   Neves, Maria G P M S ^a   Tome, Augusto C ^a   Iglesias de La Cruz, M Carmen ^b   Zamarrón, Alicia ^b   Carrasco, Elisa ^b   González, Salvador ^c   Cavaleiro, José A S ^a   Torres, Tomás ^b   Guldi, Dirk M ^d   Juarranz, Angeles ^b  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; GLYCOPHTHALOCYANINE DERIVATIVE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT EXPOSURE; METAPHASE; MITOSIS; PHOTODYNAMIC THERAPY; SPINDLE CELL; WESTERN BLOTTING;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASES; CELL LINE; CYTOSKELETON; GALACTOSE; HELA CELLS; HUMANS; INDOLES; MITOSIS; PHOTOSENSITIZING AGENTS;

EID: 84859828791     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx300035a     Document Type: Article

References (57)

1. Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., Korbelik, M., Moan, J., Mroz, P., Nowis, D., Piette, J., Wilson, B. C., and Golab, J. (2011) Photodynamic therapy of cancer: an update. CA Cancer. J. Clin. 61, 250-81.
2. Dolmans, D. E., Fukumura, D., and Jain, R. K. (2003) Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380-387. (Pubitemid 37328858)
3. Juarranz, A., Jaen, P., Sanz-Rodriguez, F., Cuevas, J., and Gonzalez, S. (2008) Photodynamic therapy of cancer. Basic principles and applications. Clin. Transl. Oncol. 10, 148-154.
4. Dumontet, C., and Jordan, M. A. (2010) Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat. Rev. Drug Discovery 9, 790-803.
5. Juarranz, A., Espada, J., Stockert, J. C., Villanueva, A., Polo, S., Dominguez, V., and Canete, M. (2001) Photodamage induced by Zinc(II)- phthalocyanine to microtubules, actin, alpha-actinin and keratin of HeLa cells. Photochem. Photobiol. 73, 283-289.
6. Galaz, S., Espada, J., Stockert, J. C., Pacheco, M., Sanz-Rodriguez, F., Arranz, R., Rello, S., Canete, M., Villanueva, A., Esteller, M., and Juarranz, A. (2005) Loss of E-cadherin mediated cell-cell adhesion as an early trigger of apoptosis induced by photodynamic treatment. J. Cell. Physiol. 205, 86-96. (Pubitemid 41262854)
7. Uzdensky, A., Kolpakova, E., Juzeniene, A., Juzenas, P., and Moan, J. (2005) The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells. Biochim. Biophys. Acta 1722, 43-50. (Pubitemid 40222404)
8. Stockert, J. C., Canete, M., Juarranz, A., Villanueva, A., Horobin, R. W., Borrell, J. I., Teixido, J., and Nonell, S. (2007) Porphycenes: facts and prospects in photodynamic therapy of cancer. Curr. Med. Chem. 14, 997-1026. (Pubitemid 46672636)
9. Espada, J., Galaz, S., Sanz-Rodriguez, F., Blazquez-Castro, A., Stockert, J. C., Bagazgoitia, L., Jaen, P., Gonzalez, S., Cano, A., and Juarranz, A. (2009) Oncogenic H-Ras and PI3K signaling can inhibit E-cadherin-dependent apoptosis and promote cell survival after photodynamic therapy in mouse keratinocytes. J. Cell. Physiol. 219, 84-93.
10. Piette, J., Volanti, C., Vantieghem, A., Matroule, J. Y., Habraken, Y., and Agostinis, P. (2003) Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem. Pharmacol. 66, 1651-9. (Pubitemid 38373358)
11. Rello-Varona, S., Stockert, J. C., Canete, M., Acedo, P., and Villanueva, A. (2008) Mitotic catastrophe induced in HeLa cells by photodynamic treatment with Zn(II)-phthalocyanine. Int. J. Oncol. 32, 1189-1196.
12. Wainwright, M. (2008) Photodynamic therapy: the development of new photosensitisers. Anticancer Agents Med. Chem. 8, 280-291.
13. Allen, C. M., Sharman, W. M., and Van Lier, J. E. (2001) Current status of phthalocyanines in the photodynamic therapy of cancer. J. Porphyrins Phthalocyanines 5, 161-169. (Pubitemid 32125237)
14. Lo, P. C., Fong, W. P., and Ng, D. K. (2008) Effects of peripheral chloro substitution on the photophysical properties and in vitro photodynamic activities of galactose-conjugated silicon(IV) phthalocyanines. ChemMedChem 3, 1110-1117.
15. Durmus, M., and Ahsen, V. (2010) Water-soluble cationic gallium(III) and indium(III) phthalocyanines for photodynamic therapy. J. Inorg. Biochem. 104, 297-309.
16. Zhou, C., Shunji, C., Jinsheng, D., Junlin, L., Jori, G., and Milanesi, C. (1996) Apoptosis of mouse MS-2 fibrosarcoma cells induced by photodynamic therapy with Zn (II)-phthalocyanine. J. Photochem. Photobiol., B 33, 219-223.
17. Cristobal, J., Stockert, J. C., Villanueva, A., Rello-Varona, S., Juarranz, A., and Canete, M. (2006) Caspase-2: a possible trigger of apoptosis induced in A-549 tumor cells by ZnPc photodynamic treatment. Int. J. Oncol. 28, 1057-1063.
18. Allen, C. M., Langlois, R., Sharman, W. M., La Madeleine, C., and Van Lier, J. E. (2002) Photodynamic properties of amphiphilic derivatives of aluminum tetrasulfophthalocyanine. Photochem. Photobiol. 76, 208-216.
19. Sharma, S. K., Dai, T., Kharkwal, G. B., Huang, Y. Y., Huang, L., De Arce, V. J., Tegos, G. P., and Hamblin, M. R. (2011) Drug discovery of antimicrobial photosensitizers using animal models. Curr. Pharm. Des. 17, 1303-1319.
20. Garland, M. J., Cassidy, C. M., Woolfson, D., and Donnelly, R. F. (2009) Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments. Future Med. Chem. 1, 667-691.
21. Qiu, T., Xu, X., Liu, J., and Qian, X. (2009) Novel perfluoroalkyl phthalocyanine metal derivatives: Synthesis and photodynamic activities. Dyes Pigm. 83, 127-133.
22. Sharman, W. M., and Van Lier, J. E. (2005) A new procedure for the synthesis of water-soluble tri-cationic and -anionic phthalocyanines. J. Porphyrins Phthalocyanines 9, 651-659.
23. Ribeiro, A. O., Tomé, J. P. C, Neves, M. G. P. M. S., Tomé, A. C., Cavaleiro, J. A. S., and Iamamoto, Y. (2006) [1,2,3,4-tetrakis- (alpha/beta-D-galactopyranos-6-yl)-phthalocyaninato]zinc(II): a water-soluble phthalocyanine. Tetrahedron Lett. 47, 9177-9180.
24. Choi, C. F., Huang, J. D., Lo, P. C., Fong, W. P., and Ng, D. K. (2008) Glycosylated zinc(II) phthalocyanines as efficient photosensitisers for photodynamic therapy. Synthesis, photophysical properties and in vitro photodynamic activity. Org. Biomol. Chem. 6, 2173-2181.
25. Soares, A. R., Tome, J. P., Neves, M. G. P. M. S., Tome, A. C., Cavaleiro, J. A., and Torres, T. (2009) Synthesis of water-soluble phthalocyanines bearing four or eight D-galactose units. Carbohydr. Res. 344, 507-510.
26. Liu, J. Y., Lo, P. C., Fong, W. P., and Ng, D. K. (2009) Effects of the number and position of the substituents on the in vitro photodynamic activities of glucosylated zinc(II) phthalocyanines. Org. Biomol. Chem. 7, 1583-1591.
27. Berg, K., Weyergang, A., Prasmickaite, L., Bonsted, A., Hogset, A., Strand, M. T., Wagner, E., and Selbo, P. K. (2010) Photochemical internalization (PCI): a technology for drug delivery. Methods Mol. Biol. 635, 133-145.
28. Selbo, P. K., Weyergang, A., Hogset, A., Norum, O. J., Berstad, M. B., Vikdal, M., and Berg, K. (2010) Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. J. Controlled Release 148, 2-12.
29. Josefsen, L. B., and Boyle, R. W. (2008) Photodynamic therapy: novel third-generation photosensitizers one step closer? Br. J. Pharmacol. 154, 1-3. (Pubitemid 351620413)
30. Tuncel, S., Dumoulin, F., Gailer, J., Sooriyaarachchi, M., Atilla, D., Durmus, M., Bouchu, D., Savoie, H., Boyle, R. W., and Ahsen, V. (2010) A set of highly water-soluble tetraethyleneglycol-substituted Zn(ii) phthalocyanines: synthesis, photochemical and photophysical properties, interaction with plasma proteins and in vitro phototoxicity. Dalton Trans. 40, 4067-4079.
31. Dwek, R. A. (1996) Glycobiology: Toward understanding the function of sugars. Chem. Rev. 96, 683-720.
32. Liu, J. Y., Lo, P. C., Jiang, X. J., Fong, W. P., and Ng, D. K. (2009) Synthesis and in vitro photodynamic activities of di-alpha-substituted zinc(ii) phthalocyanine derivatives. Dalton Trans. 21, 4129-4135.
33. Zheng, G., Graham, A., Shibata, M., Missert, J. R., Oseroff, A. R., Dougherty, T. J., and Pandey, R. K. (2001) Synthesis of α-galactose- conjugated chlorins derived by enyne metathesis as galectin-specific photosensitizers for photodynamic therapy. J. Org. Chem. 66, 8709-8716. (Pubitemid 34042233)
34. Vedachalam, S., Choi, B., Pasunooti, K. K., Ching, K. M., Lee, K., Yoon, H. S., and Liu, X. W. (2011) Glycosylated porphyrin derivatives and their photodynamic activity in cancer cells. Med. Chem. Commun. 2, 371-377.
35. Williams, A. T. R., Winfield, S. A., and Miller, J. N. (1983) Relative fluorescence quantum yields using a computer-controlled luminescence spectrometer. Analyst 108, 1067-1071.
36. Villanueva, A., Dominguez, V., Polo, S., Vendrell, V. D., Sanz, C., Canete, T. M., Juarranz, A., and Stockert, J. C. (1999) Photokilling mechanisms induced by zinc(II)-phthalocyanine on cultured tumor cells. Oncol. Res. 11, 447-453.
37. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
38. Seotsanyana-Mokhosi, I., Kuznetsova, N., and Nyokong, T. (2001) Photochemical studies of tetra-2,3-pyridinoporphyrazines. J. Photochem. Photobiol., A 140, 215-222.
39. Rello, S., Stockert, J. C., Moreno, V., Gamez, A., Pacheco, M., Juarranz, A., Canete, M., and Villanueva, A. (2005) Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 10, 201-208. (Pubitemid 40558128)
40. Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., Hengartner, M., Knight, R. A., Kumar, S., Lipton, S. A., Malorni, W., Nunez, G., Peter, M. E., Tschopp, J., Yuan, J., Piacentini, M., Zhivotovsky, B., and Melino, G. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16, 3-11.
41. Jiménez-Banzo, A., Sagristá, M. L., Mora, M., and Nonell, S. (2008) Kinetics of singlet oxygen photosensitization in human skin fibroblasts. Free Radical Biol. Med. 44, 1926-1934.
42. Da Silva, E. F. F., Pedersen, B. W., Breitenbach, T., Toftegaard, R., Kuimova, M. K., Arnaut, L. G., and Ogilby, P. R. (2012) Irradiation- and sensitizer-dependent changes in the lifetime of intracellular singlet oxygen produced in a photosensitized process. J. Phys. Chem. B 116, 445-461.
43. Dhami, S., and Phillips, D. (1996) Comparison of the photophysics of an aggregating and non-aggregating aluminium phthalocyanine system incorporated into unilamellar vesicles. J. Photochem. Photobiol., A 100, 77-84.
44. Koval'skaya, N. E., Kuznetsova, N. A., Kaliya, O. L., Gretsova, N. S., and Sokolova, I. V. (2001) The efficiency of the formation of singlet oxygen by a sensitizer based on zinc phthalocyanine. J. Appl. Spectrosc. 68, 287-290. (Pubitemid 33328193)
45. Vantieghem, A., Xu, Y., Assefa, Z., Piette, J., Vandenheede, J. R., Merlevede, W., De Witte, P. A., and Agostinis, P. (2002) Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis. J. Biol. Chem. 277, 37718-37731.
46. Piette, J., Volanti, C., Vantieghem, A., Matroule, J. Y., Habraken, Y., and Agostinis, P. (2003) Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem. Pharmacol. 66, 1651-1659. (Pubitemid 38373358)
47. Ferenc, P., Solár, P., Kleban, J., Mikes, J., and Fedorocko, P. (2010) Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells. J. Photochem. Photobiol., 98, 25-34.
48. Compagnin, C., Mognato, M., Celotti, L., Canti, G., Palumbo, G., and Reddi, E. (2010) Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy. Cell Proliferation 43, 262-74.
49. Portugal, J., Mansilla, S., and Bataller, M. (2000) Mechanisms of drug-induced mitotic catastrophe in cancer cells. Curr. Pharm. Des. 16, 69-78.
50. Wu, Y. C., Yen, W. Y., Ho, H. Y., Su, T. L., and Yih, L. H. (2010) Glyfoline induces mitotic catastrophe and apoptosis in cancer cells. Int. J. Cancer 126, 1017-1028.
51. Mena, A. L., Lam, E. W., and Chatterjee, S. (2010) Sustained spindle-assembly checkpoint response requires de novo transcription and translation of cyclin B1. PLoS One 5 (9), e13037.
52. Gong, D., and Ferrell, J. E. Jr. (2010) The roles of cyclin A2, B1, and B2 in early and late mitotic events. Mol. Biol. Cell 21, 3149-3161.
53. Sabisz, M., Wesierska-Gadek, J., and Skladanowski, A. (2010) Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints. Biochem. Pharmacol. 79, 1387-1397.
54. Kim, J. K., and Diehl, J. A. (2009) Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell. Physiol. 220, 292-296.
55. Witzel, I. I., Koh, L. F., and Perkins, N. D. (2010) Regulation of cyclin D1 gene expression. Biochem. Soc. Trans. 38, 217-222.
56. Bhuvaneswari, R., Gan, Y. Y., Soo, K. C., and Olivo, M. (2009) Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. Mol. Cancer 8, 94.
57. Ozmen, A., Bauer, S., Gridling, M., Singhuber, J., Krasteva, S., Madlener, S., Vo, T. P., Stark, N., Saiko, P., Fritzer-Szekeres, M., Szekeres, T., Askin-Celik, T., Krenn, L., and Krupitza, G. (2009) In vitro anti-neoplastic activity of the ethno-pharmaceutical plant Hypericum adenotrichum Spach endemic to Western Turkey. Oncol. Rep. 22, 845-852.